Tradename | Company | Number | Date | Products |
---|---|---|---|---|
XARELTO | Johnson & Johnson | N-022406 RX | 2011-07-01 | 4 products, RLD |
XARELTO | Johnson & Johnson | N-215859 RX | 2021-12-20 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
rivaroxaban | ANDA | 2025-05-20 |
xarelto | New Drug Application | 2025-04-07 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
venous thrombosis | — | D020246 | I82.40 |
pulmonary embolism | EFO_0003827 | D011655 | I26 |
Expiration | Code | ||
---|---|---|---|
RIVAROXABAN, XARELTO, JANSSEN PHARMS | |||
2025-06-20 | PED | ||
2025-02-23 | PED | ||
2024-12-20 | NP | ||
2024-08-23 | I-867 | ||
2023-09-10 | PED | ||
2023-04-11 | PED | ||
2023-03-10 | M-284 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Rivaroxaban, Xarelto, Janssen Pharms | |||
10828310 | 2039-01-31 | U-3207, U-3208 | |
9539218 | 2034-02-17 | U-1953, U-1954, U-1955, U-1957, U-2143, U-2641, U-3285, U-3288, U-3289 | |
9415053 | 2024-11-13 | DP | U-1167, U-1200, U-1301, U-1302, U-2142, U-2435, U-2640, U-3205, U-3206, U-3284, U-3286, U-3287 |
7157456 | 2024-08-28 | DS, DP | U-1301, U-1302 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | 2 | 5 | 7 | 3 | 47 | 63 |
Thromboembolism | D013923 | — | — | 3 | 7 | 15 | 1 | 20 | 45 |
Venous thromboembolism | D054556 | EFO_0004286 | I74 | 1 | 6 | 14 | 1 | 20 | 42 |
Thrombosis | D013927 | — | — | 7 | 6 | 10 | 2 | 15 | 39 |
Embolism | D004617 | — | — | 2 | — | 6 | 4 | 15 | 27 |
Venous thrombosis | D020246 | — | I82.40 | 4 | 5 | 6 | 1 | 10 | 26 |
Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | — | 4 | 4 | 9 | 17 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | 3 | 1 | 7 | 12 |
Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | 2 | 2 | 3 | 7 |
Coronary artery disease | D003324 | — | I25.1 | — | 1 | 1 | 2 | 2 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acute coronary syndrome | D054058 | EFO_0005672 | — | — | 2 | 1 | — | 5 | 8 |
Renal insufficiency | D051437 | — | N19 | 1 | — | 1 | — | 2 | 4 |
Infarction | D007238 | EFO_0009463 | — | — | — | 2 | — | 1 | 3 |
Heart failure | D006333 | EFO_0003144 | I50 | — | — | 2 | — | 1 | 3 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 1 | — | 1 | 2 |
Rheumatic diseases | D012216 | — | M79.0 | — | — | 2 | — | — | 2 |
Percutaneous coronary intervention | D062645 | — | — | — | — | 1 | — | 1 | 2 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | 2 | — | — | 2 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | — | 1 | — | — | 2 |
Hematoma | D006406 | EFO_0010680 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ischemic stroke | D000083242 | — | — | — | 1 | — | — | 3 | 4 |
Ischemia | D007511 | EFO_0000556 | — | — | 1 | — | — | 2 | 3 |
Transient ischemic attack | D002546 | EFO_0003764 | G45.9 | — | 1 | — | — | 1 | 2 |
Bariatric surgery | D050110 | — | — | 1 | 1 | — | — | — | 2 |
Cerebral infarction | D002544 | — | I63 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 6 | — | — | — | 1 | 7 |
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Biological availability | D001682 | — | — | 2 | — | — | — | — | 2 |
Morbid obesity | D009767 | EFO_0001074 | — | 1 | — | — | — | — | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | — | 1 |
Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | 1 | — | — | — | — | 1 |
Disease | D004194 | EFO_0000408 | R69 | 1 | — | — | — | — | 1 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | 1 | — | — | — | — | 1 |
Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Replacement arthroplasty knee | D019645 | — | — | — | — | — | — | 2 | 2 |
Replacement arthroplasty hip | D019644 | — | — | — | — | — | — | 2 | 2 |
Intracranial hemorrhages | D020300 | EFO_0000551 | I62 | — | — | — | — | 1 | 1 |
Disease progression | D018450 | — | — | — | — | — | — | 1 | 1 |
Brain ischemia | D002545 | EFO_0003883 | I67.82 | — | — | — | — | 1 | 1 |
Congenital heart defects | D006330 | — | Q24.9 | — | — | — | — | 1 | 1 |
Fontan procedure | D018729 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Rivaroxaban |
INN | rivaroxaban |
Description | Rivaroxaban is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-chlorothiophene-2-carboxylic acid with the amino group of 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one. It is an anticoagulant used for prophylaxis of venous thromboembolism in patients with knee or hip replacement surgery. It has a role as an anticoagulant and an EC 3.4.21.6 (coagulation factor Xa) inhibitor. It is a member of thiophenes, an organochlorine compound, an oxazolidinone, a member of morpholines, a lactam, an aromatic amide and a monocarboxylic acid amide. Rivaroxaban is an orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral administration, rivaroxaban selectively binds to both free factor Xa and factor Xa bound in the prothrombinase complex. This interferes with the conversion of prothrombin (factor II) to thrombin and eventually prevents the formation of cross-linked fibrin clots. Rivaroxaban does not affect existing thrombin levels. |
Classification | Small molecule |
Drug class | antithrombotics, blood coagulation factor XA inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1 |
PDB | — |
CAS-ID | 366789-02-8 |
RxCUI | — |
ChEMBL ID | CHEMBL198362 |
ChEBI ID | 68579 |
PubChem CID | 9875401 |
DrugBank | DB06228 |
UNII ID | 9NDF7JZ4M3 (ChemIDplus, GSRS) |